Perspective Therapeutics CATX Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's other income (expense)?
- Perspective Therapeutics (CATX) reported other income (expense) of $2.09M in Q1 2026.
- How has Perspective Therapeutics's other income (expense) changed year-over-year?
- Perspective Therapeutics's other income (expense) decreased by 42.8% year-over-year, from $3.66M to $2.09M.
- What is the long-term trend for Perspective Therapeutics's other income (expense)?
- Over 2 years (2023 to 2025), Perspective Therapeutics's other income (expense) has grown at a 230.8% compound annual growth rate (CAGR), from $835K to $9.14M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.